Serialization Pharma Information Webinars
Pharma Information Email List Stay on top of the latest requirements As many of you may be getting questions or have concerns about your compliance and changing rules to the DSCSA and Pharma specific issues, We have created this list to outline how the MDS system will help you address these challenges. FDA Announces Enforcement Discretion Guidance for DSCSA Verification Requirement FDA has announced that, given concerns expressed by stakeholders and to minimize possible disruptions in the pharmaceutical distribution supply chain, it does not intend to act against wholesale distributors who do not, prior to November 27, 2020, verify a product identifier before distributing a returned product as required under the DSCSA. Having said that, We still need to address the issue , we just have a little more time. The goal of this email list is to point out our suggested best (business) practices. While we do not enforce or force you to follow these rules, this list is intended...